Marshall Wace North America’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$282K Buy
+26,362
New +$282K ﹤0.01% 1208
2019
Q2
Sell
-4,522
Closed -$111K 1338
2019
Q1
$111K Sell
4,522
-6,815
-60% -$167K ﹤0.01% 1096
2018
Q4
$294K Buy
+11,337
New +$294K ﹤0.01% 892
2018
Q3
Sell
-156,298
Closed -$6.07M 1109
2018
Q2
$6.07M Buy
+156,298
New +$6.07M 0.03% 466